MARIBEL DE PONCE: Open Payments
NPI 1003047523 · BUDA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,387 in 52 payments from 10 companies in 2025. Trend: 2023 $653 · 2024 $725 · 2025 $1,387
Food & beverage: $1,387
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 19 | $419 |
| Gilead Sciences, Inc. | 7 | $195 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $186 |
| Janssen Biotech, Inc. | 4 | $154 |
| Novo Nordisk Inc | 4 | $150 |
| Boston Scientific Corporation | 1 | $120 |
| ABBVIE INC. | 4 | $66 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| Ardelyx, Inc. | 2 | $36 |
| PFIZER INC. | 1 | $24 |
Products named: IQIRVO, XIFAXAN, TREMFYA, Bylvay, Wegovy, Axonics, Livdelzi, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
